Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0007 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0008 |
mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0009 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.001 |
mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.001 |